Drug Keytruda May Help Block Melanoma's Return

MONDAY, April 16, 2018 — Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients’ risk of their cancer returning, a new study found.
Last May, Keytruda (pembrolizumab) became the first ever drug approved by the…
Source: Topamax